Combined Spinal Epidural Anesthesia in Obese Patients Undergoing Cesarean Surgery

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

February 1, 2017

Primary Completion Date

March 1, 2018

Study Completion Date

April 5, 2018

Conditions
ObesityPregnancy RelatedCesarean Section ComplicationsSpinal Anaesthetic Poisoning of Undetermined IntentHypotension
Interventions
OTHER

left lateral decubitus position

Comparator group consisted of patients performing CSEA in the left lateral decubitus position.

OTHER

sitting position

Active control group consisted of patients performing CSEA in the sitting position.

DRUG

The use of intravenous ephedrine.

Intravenous ephedrine (6 mg) was used to treat hypotension (a 30% decrease in systolic blood pressure compared to preoperative values) during surgery.

DRUG

The use of intravenous atropine.

Intravenous atropine (1 mg) was given in case of bradycardia (the heart rate \< 45 beats/minute) during surgery.

DRUG

The use of intravenous metoclopramide

When nausea and vomiting were observed, intravenous metoclopramide (10 mg) was administered.

Trial Locations (1)

25240

Mehmet AKSOY, Erzurum

All Listed Sponsors
lead

Ataturk University

OTHER

NCT04612998 - Combined Spinal Epidural Anesthesia in Obese Patients Undergoing Cesarean Surgery | Biotech Hunter | Biotech Hunter